Moelis & Company stock gets a neutral UBS rating at USD 59

Published on 10/08/2026 at 01:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Moelis & Company stock was last at USD 56.15 on October 7, 2026, while UBS moved from Sell to Neutral and set a USD 59 target. Q2 revenue rose 12 percent to USD 409.39 million.

MC, US60786M1053, Illustration mit AI erstellt.

Moelis & Company stock (ISIN US60786M1053) was last at USD 56.15 on the NYSE on October 7, 2026 at 4:00 p.m. ET, up 0.18 percent from the prior close. The immediate catalyst was UBS moving the investment bank from Sell to Neutral while lowering its price target from USD 60 to USD 59.

UBS cuts target to USD 59

According to Investing.com on October 7, 2026, UBS cited a challenging mergers and acquisitions backdrop and softer sponsor activity. The bank also said its outlook sits below consensus for 2027 and 2028.

The revised USD 59 target is 5.07 percent above the October 7 price of USD 56.15. That gap is narrower than the broader analyst view, making the UBS action a cautious change in rating rather than a bullish target reset.

Q2 revenue reaches USD 409.39 million

MarketBeat reported on October 7, 2026 that Moelis generated USD 409.39 million of revenue in Q2 2026, up 12 percent from the prior-year quarter. Revenue also exceeded the USD 387.27 million analyst estimate by USD 22.12 million.

The earnings comparison gives the rating change useful context. Moelis delivered top-line growth in the latest reported quarter, while UBS focused on the future pace of sponsor-led deal activity and the risk that estimates may move lower.

Stock sits 28.22 percent below its high

The USD 56.15 price stood 28.22 percent below the 52-week high of USD 78.22 and USD 5.09 above the 52-week low of USD 51.06 on October 7, 2026. Trading volume reached 1,443,895 shares, while market capitalization was USD 4.2 billion.

According to Investing.com, the consensus rating is Neutral among 11 analysts, with an average 12-month price target of USD 71.00. The target is 26.45 percent above the October 7 price, while the published high and low targets are USD 86.00 and USD 58.00.

Moelis stock heads toward November results

For investors, the central tension is visible in the numbers: Q2 revenue grew 12 percent, yet the latest UBS target remains below the broader USD 71.00 consensus. Moelis is scheduled to report its next quarterly results on November 4, 2026.